Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

    Forecasted

    This grant funds a national research network to study how cancer and normal tissues respond biologically to radiation therapy, aiming to improve treatment and discover new therapy opportunities.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

    This upcoming NIH grant will fund innovative research developing advanced bioinformatics and computational biology tools to improve biomedical data analysis and health outcomes, encouraging interdisciplinary and technology-driven projects.

    HHS-NIH11Due Feb 5, 2027$1,000,000

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted

    Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

    This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.

    HHS-NIH11Due Jan 7, 2027

    RNomics Outreach and Coordination (ROC) Center

    The RNomics Outreach and Coordination (ROC) Center will manage data, coordinate activities, and support outreach and training for a consortium advancing RNA research technologies and resources.

    HHS-NIH11Forecasted Feb 1, 2027$3,500,000Forecasted

    Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)

    This limited competition funds continued operation of National Cancer Institute biospecimen banks supporting national, early-phase, and experimental cancer clinical trials and translational research.

    HHS-NIH11Due Feb 11, 2027$18,000,000